KEGG   DRUG: Batiraxcept
Entry
D12271                      Drug                                   
Name
Batiraxcept (USAN)
Formula
C4166H6450N1130O1290S26
Exact mass
93780.6588
Mol weight
93838.33
Sequence
EESPFVSNPG NITGARGLTG TLRCQLQVQG EPPEVHWLRD GQILELVDST QTQVPLGEDE
QGDWIVASQL RITSLQLSDT GQYQCLVFLG HQTFVSQPGY VRLEGLPYFL EEPEDRTVAA
NTPFNLSCQA QGPPEPVDLL WLQDAVPLAT APGHGPQRSL HVPGLNKTSS FSCEAHNAKG
VTTSRTATIT VLPQQGGGGS DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT
CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK
CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK NQVSLTCLVK GFYPSDIAVE
WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS
LSLSPG
(Disulfide bridge: 24-85, 128-173, 206-206', 209-209', 241-301, 341-405, 24'-85', 128'-173', 241'-301', 347'-405)
  Type
Peptide
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
Efficacy
Antineoplastic, Receptor tyrosine kinase inhibitor
Comment
Treatment of ovarian cancer
Target
AXL [HSA:558] [KO:K05115]
Interaction
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    D12271  Batiraxcept
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   AXL family
    AXL
     D12271  Batiraxcept (USAN)
Other DBs
CAS: 2268717-61-7
PubChem: 497620684
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system